Labcorp Holdings Diagnostics — Goodwill increased by 3.2% to $5.61B in Q1 2026 compared to the prior quarter.
High levels indicate significant historical M&A activity; sudden decreases may signal impairment charges due to underperforming acquisitions.
This represents the intangible asset value recorded when the diagnostics segment acquires other businesses for a price e...
Common in consolidated healthcare firms that grow through frequent strategic acquisitions.
lh_segment_diagnostics_goodwill| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $4.05B | $4.53B | $4.81B | $5.10B | $5.17B | $5.33B | $5.43B | $5.61B |
| QoQ Change | — | +12.0% | +6.2% | +6.0% | +1.2% | +3.2% | +1.9% | +3.2% |
| YoY Change | — | +12.0% | +6.2% | +6.0% | — | — | +6.5% | — |